1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Tumor Ablation Market 2015-2019

Global Tumor Ablation Market 2015-2019

  • December 2015
  • -
  • Infiniti Research Limited
  • -
  • 70 pages

Market outlook of the global tumor ablation market

Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.

Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019.

Segmentation by ablation technology and analysis of the tumor ablation market

Radiofrequency
Ultrasound
Cryotherapy
Microwave
In this market research report, Technavio analysts estimate the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.

Cancer-type segmentation of the tumor ablation market

Liver
Breast
Prostate
Gynecological
Lung
ENT
Technavios analyst has estimated the liver cancer segment to account for the highest market share during the forecast period. Liver cancer is more common in men than in women and is characterized by uncontrolled cell division in the liver. High incidence of primary liver cancer and bile duct cancer among the populace will result in this segments high market dominion during the forecast period.


Competitive landscape and key vendors

This market offers ample growth opportunities to vendors during the forecast period and is characterized by the presence of numerous local and multinational vendors. While the international players are continually increasing their footprint in the market through product innovations, local vendors adopt collaborations to stay competitive in the market.

Leading vendors in this market are-

AngioDynamics
Boston Scientific
Ethicon
Medtronic
Other prominent vendors are Alpinion Medical System, BSD Medical, Conmed, C2 Therapeutics, CSA Medical, C.R. Bard, Chongqing Haifu Medical Technology, Esaote, EDAP TMS, Galil Medical, InSightec, Misonix, Mermaid Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Plasma Surgical, Profound Medical, Philips Healthcare, Smith & Nephews, Sonacare Medical, Shenzhen Huikang Medical Apparatus, Terumo Medical, Total Vein Systems, Theraclion, and Vivant Medical.


Key questions answered in the report include

What will the market size and the growth rate be in 2019
What are the key factors driving the global tumor ablation market
What are the key market trends impacting the growth of the global tumor ablation market
What are the challenges to market growth
Who are the key vendors in the global tumor ablation market
What are the market opportunities and threats faced by the vendors in the global tumor ablation market
Trending factors influencing the market shares of the EMEA, Americas, and APAC
What are the key outcomes of the five forces analysis of the global tumor ablation market
Technavio also offers customization on reports based on specific client requirement.


Related reports

Ablation Catheters Market in Europe 2015-2019
Ablation Catheters Market in the US 2015-2019
Global Radiofrequency Ablation Devices Market 2015-2019
Global Kidney Cancer Drugs Market 2015-2019

Table Of Contents

Global Tumor Ablation Market 2015-2019
Table of Contents
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Cancer statistics
PART 06: Pipeline analysis
PART 07: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 08: Market segmentation by ablation technology
- Radiofrequency ablation
- Ultrasound ablation
- Cryoablation
- Microwave ablation
PART 09: Market segmentation by cancer types
- Liver cancer
- Breast cancer
- Prostate cancer
- Gynecological cancer
- Lung cancer
- Ear, nose, and throat cancers
PART 10: Geographical segmentation
- Segmentation of global tumor ablation market by geography 2014-2019
- Tumor ablation market in Americas
- Tumor ablation market in EMEA
- Tumor ablation market in APAC
PART 11: Market drivers
- Increase in minimally invasive surgeries/procedures
- Rise in number of outpatient procedures
- Advances in technology
- Use of medical lasers for oncology procedures
PART 12: Impact of drivers
PART 13: Market challenges
- High cost of surgeries
- Risks associated with unskilled practitioners
- Risks associated with laser tumor ablation treatments
- Stringent regulatory approval process
PART 14: Impact of drivers and challenges
PART 15: Market trends
- Use of robotic navigation technologies
- Growing focus on emerging countries
- Focus on RandD
- Rise in accessibility of advanced laser treatments
PART 16: Vendor landscape
- Competitive scenario
- Key vendor analysis 2014
- Other prominent vendors
PART 17: Key vendor analysis
- AngioDynamics
- Boston Scientific
- Ethicon
- Medtronic
PART 18: Appendix
- List of abbreviations
PART 19: Explore Technavio



List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Most prevalent cancer types in the world 2012
Exhibit 03: Countries with the highest cancer rate 2012
Exhibit 04: Pipeline analysis for tumor ablation devices
Exhibit 05: Global tumor ablation market segmentation
Exhibit 06: Global tumor ablation market 2014-2019 ($ millions)
Exhibit 07: Five forces analysis
Exhibit 08: Segmentation of global tumor ablation market by technology
Exhibit 09: Segmentation of global tumor ablation market by ablation technology 2014
Exhibit 10: Segmentation of global tumor ablation market by cancer types
Exhibit 11: Segmentation of global tumor ablation market by cancer type 2014
Exhibit 12: Segmentation of global tumor ablation market by geography 2014
Exhibit 13: Segmentation of global tumor ablation market by geography 2019
Exhibit 14: Segmentation of global tumor ablation market by geography 2014-2019
Exhibit 15: Image-guided minimally invasive procedures 2012 (million/year)
Exhibit 16: Tumor ablation market in Americas 2014-2019 ($ millions)
Exhibit 17: Prostate cancer incidence in top five European countries 2012
Exhibit 18: Tumor ablation market in EMEA 2014-2019 ($ millions)
Exhibit 19: Tumor ablation market in APAC 2014-2019 ($ millions)
Exhibit 20: Impact of drivers
Exhibit 21: Cost comparison of various tumor ablation procedures
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Country wise healthcare spending 2010-2016 estimated ($ billions)
Exhibit 24: AngioDynamics: Key takeaways
Exhibit 25: Boston Scientific: Key takeaways
Exhibit 26: Ethicon: Key takeaways
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: AngioDynamics: Business segmentation by revenue 2015
Exhibit 29: AngioDynamics: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 30: AngioDynamics: Segmentation of revenue by geography 2015
Exhibit 31: Boston Scientific: Business segmentation by revenue 2014
Exhibit 32: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 33: Ethicon : Product segmentation
Exhibit 34: Medtronic: Business segmentation 2015 by revenue
Exhibit 35: Medtronic: Business segmentation by revenue 2014 and 2015 ($ billions)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global tumor ablation market is estimated to register a high CAGR of 12.5% during 2016-2021, and is expected to be valued at ~USD 580.1 million in 2021. Although mature markets (North America and Europe) ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.